Merck KGaA, Novartis lead race to launch first MS pill

02/12/2009 | Bloomberg

Novartis AG and Merck KGaA are the front-runners in the race to launch the first oral medicine for multiple sclerosis, with both planning to seek regulatory approval this year for their drugs. Not far behind are Teva Pharmaceutical Industries, Biogen Idec and Sanofi-Aventis, which are expected to release their versions no earlier than 2012.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA